| 13623 |
Leronlimab (Pro 140) Cliff Notes What is it?  (37) |
trding |
12/24/2019 8:09:27 PM |
| 112006 |
Leronlimab - Disease List (currently 90) (updated (28) |
ohm20 |
12/09/2021 8:15:12 AM |
| 144440 |
Leronlimab Regulator List (a work in progress) = (14) |
ohm20 |
06/12/2024 7:33:56 PM |
| 145805 |
Here's some basics on the science - Leronlimab (43) |
ohm20 |
08/21/2024 12:48:53 PM |
|
146977 |
I'm not a basher, but I'm on the underwhelmed (6) |
SamaGong |
10/08/2024 10:34:04 AM |
|
146976 |
This is a really interesting and exciting hire to (22) |
Katangolo |
10/08/2024 10:33:20 AM |
|
146975 |
"Put me in coach" --"I am ready to leverage my |
My69z |
10/08/2024 10:21:07 AM |
|
146974 |
The company is certainly putting a lot of runners (2) |
Mr3Putt |
10/08/2024 9:53:50 AM |
|
146973 |
That is what I am feeling. The "goody bag" added |
mountaineer |
10/08/2024 9:45:37 AM |
|
146972 |
Has anyone else noticed the strange absence of (1) |
Drano |
10/08/2024 9:42:47 AM |
|
146971 |
Does it feel like we are just building up for (11) |
Riztheinvestor |
10/08/2024 9:36:28 AM |
|
146970 |
Dr. Lataillade aligns with Syneos: "...with |
My69z |
10/08/2024 8:59:05 AM |
|
146969 |
CytoDyn Appoints Dr. Max Lataillade as Senior (5) |
docj |
10/08/2024 8:43:45 AM |
|
146968 |
No problem. Dr. Max Lataillade has a very (1) |
Riztheinvestor |
10/08/2024 8:41:35 AM |
|
146967 |
https://www.cytodyn.com/newsroom/press-releases/d (2) |
Riztheinvestor |
10/08/2024 8:31:05 AM |
|
146966 |
So if TAS is knocking out neutrophils while (1) |
MGK_2 |
10/08/2024 7:59:08 AM |
|
146965 |
inflammaging? (2) |
hoops |
10/08/2024 6:23:15 AM |
|
146964 |
Making different LL variants, will equal (1) |
My69z |
10/08/2024 1:36:37 AM |
|
146963 |
FcRn LS in our Covid patent: In some embodiments, |
My69z |
10/08/2024 1:14:04 AM |
|
146962 |
Refractory microsatellite stable (MSS) colorectal (3) |
My69z |
10/07/2024 9:46:57 PM |
|
146961 |
Madrigal @ $214.83...up $6.42 for the (2) |
sean007 |
10/07/2024 9:44:24 PM |
|
146960 |
In the weaning process and reduction of (4) |
sean007 |
10/07/2024 9:09:38 PM |
|
146959 |
Vector & Placenta excerpts, support each other. (2) |
My69z |
10/07/2024 7:32:34 PM |
|
146958 |
Bevacizumab profile: (5) |
My69z |
10/07/2024 7:14:12 PM |
|
146957 |
Thanks. These data are truly (1) |
Katangolo |
10/07/2024 5:39:17 PM |
|
146956 |
Very positive CEO comments indeed. And perhaps we (7) |
MJS719 |
10/07/2024 5:38:37 PM |
|
146955 |
Feels like the habit-breaking Monday during (7) |
cardamine |
10/07/2024 4:48:03 PM |
|
146954 |
I just listened to it. Here is a link.: (17) |
Katangolo |
10/07/2024 4:43:03 PM |
|
146953 |
Are we expecting any news from Madrigal's |
rodolfo |
10/07/2024 3:38:05 PM |
|
146952 |
I agree regarding the uplisting. However, I do (5) |
mountaineer |
10/07/2024 3:18:44 PM |
|
146951 |
Were not up listing anytime soon, but Im (12) |
Evil Rabbit |
10/07/2024 2:13:15 PM |
|
146950 |
Just goes to show that a small phase 2 trial can (20) |
ohm20 |
10/07/2024 1:44:55 PM |
|
146949 |
You bring on Gaginer to help you move to the next (7) |
biloxiblues |
10/07/2024 1:44:21 PM |
|
146948 |
just curious if bevacizumab was held to the (10) |
ohm20 |
10/07/2024 1:37:47 PM |
|
146947 |
Sorry...the dumb hillbilly here again...I will (4) |
mountaineer |
10/07/2024 1:04:30 PM |
|
146946 |
A phase 2 refractory CRC trial with the (9) |
ohm20 |
10/07/2024 12:57:58 PM |
|
146945 |
"short seller defences, and litigation (6) |
sunray3 |
10/07/2024 12:47:29 PM |
|
146944 |
bevacizumab approval process - was there any bias (6) |
seemingly-harmless |
10/07/2024 12:05:30 PM |
|
146943 |
I like the mid day PR. Maybe something big will (2) |
Riztheinvestor |
10/07/2024 12:01:04 PM |
|
146942 |
Operates out of their new Toronto (1) |
sean007 |
10/07/2024 11:53:03 AM |
|
146941 |
Nice! |
docj |
10/07/2024 11:40:42 AM |
|
146940 |
Looks like we have a new PR firm. The name of the (25) |
Evil Rabbit |
10/07/2024 11:36:38 AM |
|
146939 |
"Planet of the Apes"...lima, Peru,...three days (6) |
sean007 |
10/07/2024 11:29:18 AM |
|
146938 |
CytoDyn Announces Abstract that Highlights (3) |
docj |
10/07/2024 11:25:30 AM |
|
146937 |
The "goody bag" continues to get (2) |
mountaineer |
10/07/2024 11:16:26 AM |
|
146936 |
https://www.cytodyn.com/newsroom/press-releases/d (10) |
Riztheinvestor |
10/07/2024 11:06:11 AM |
|
146935 |
Ah, thank you for the explanation -- I guess I (4) |
cardamine |
10/07/2024 10:58:59 AM |
|
146934 |
IMO it's not just the FDA we are trying to (10) |
Figgs |
10/07/2024 8:23:33 AM |
|
146933 |
Understand your concerns, Evil, and it is true (14) |
KenChowder |
10/07/2024 8:02:34 AM |
|
146932 |
why only 5 in the LL-only?? What do you mean by (21) |
ohm20 |
10/07/2024 2:41:56 AM |
|
146931 |
Lishomwa (Lish) Ndhlovu: Under Authors (4) |
My69z |
10/07/2024 12:31:23 AM |
|
146930 |
I am sure they will not repeat the same mistake (5) |
AeroDude |
10/06/2024 9:55:43 PM |
|
146929 |
Our Dr. Hansen & Cytomegalovirus: " Dr. Hansen (6) |
My69z |
10/06/2024 9:42:41 PM |
|
146928 |
Syneos & Zika: Principal Investigator: Vadim (3) |
My69z |
10/06/2024 9:23:09 PM |
